Washington Trust Advisors’s Zimmer Biomet ZBH Stock Holding History

Washington Trust Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27K	Sell	14 -214	-94%	-$19.6K	﹤0.01%	623
2025 Q4	$20.5K	Hold	228	–	–	﹤0.01%	436
2025 Q3	$22.5K	Hold	228	–	–	﹤0.01%	429
2025 Q2	$20.8K	Sell	228 -34	-13%	-$3.29K	﹤0.01%	397
2025 Q1	$29.7K	Buy	+262	New	+$28K	﹤0.01%	363
2023 Q2	–	Sell	-41	Closed	-$5.3K	–	778
2023 Q1	$5.3K	Hold	41	–	–	﹤0.01%	595
2022 Q4	$5.23K	Sell	41 -188	-82%	-$21.8K	﹤0.01%	598
2022 Q3	$24K	Buy	229 +2	+0.9%	+$219	﹤0.01%	492
2022 Q2	$24K	Hold	227	–	–	﹤0.01%	517
2022 Q1	$29K	Sell	227 -232	-51%	-$28K	﹤0.01%	534
2021 Q4	$57K	Buy	+459	New	+$60.1K	﹤0.01%	450

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Washington Trust Advisors's ZBH Position: Q1 2026 in Review

Washington Trust Advisors reduced its Zimmer Biomet (ZBH) stake by 94% in Q1 2026, selling an estimated $19.6K and leaving 14 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

Washington Trust Advisors first reported a position in ZBH in Q4 2021 and has held it in 11 quarters since. The position peaked at $57K in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Washington Trust Advisors held 14 shares of Zimmer Biomet worth $1.27K as of Q1 2026.
Washington Trust Advisors sold 214 Zimmer Biomet shares in Q1 2026, an estimated $19.6K.
Zimmer Biomet made up ﹤0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #623 holding.
Washington Trust Advisors first reported a position in Zimmer Biomet in Q4 2021 and has held it in 11 quarters since.
Washington Trust Advisors's Zimmer Biomet position peaked at $57K in Q4 2021.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.